Inhibition of P-glycoprotein by orange juice components, polymethoxyflavones in adriamycin-resistant human myelogenous leukemia (K562/ADM) cells

被引:89
作者
Ikegawa, T
Ushigome, F
Koyabu, N
Morimoto, S
Shoyama, Y
Naito, M
Tsuruo, T
Ohtani, H
Sawada, Y
机构
[1] Kyushu Univ, Grad Sch Pharmaceut Sci, Dept Biopharmaceut, Higashi Ku, Fukuoka 8128582, Japan
[2] Univ Tokyo, Inst Mol & Cellular Biosci, Bunkyo Ku, Tokyo 1130032, Japan
关键词
grapefruit juice; orange juice; methoxyflavone; vincristine; multidrug resistance; cancer chemotherapy;
D O I
10.1016/S0304-3835(00)00549-8
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
We investigated the effects of the ethyl acetate extract of grapefruit juice (GFJ), that of orange juice (OJ) and their components on the uptake of [H-3]vincristine into adriamycin-resistant human myelogenous leukemia cells. Its uptake was increased by the extracts of GFJ and OJ up to 7- and 3-fold, respectively, as well as verapamil and cyclosporin A. OJ components, i.e. 3,3',4'.5.6,7,8-heptamethoxyflavone, nobiletin and tangeretin, also increased the uptake of [H-3]vincristine in a concentration-dependent manner. Although GFJ components, dihydroxybergamottin and bergamottin, significantly increased the uptake, their potencies were considerably weaker than those of OJ components. These data suggest that OJ components inhibit P-gp-mediated efflux of [H-3]vincristine, resulting in the intracellular accumulation of chamotherapeutic drugs. These components may become candidates of multi-drug resistance reversing agents in cancer chemotherapy. (C) 2000 Elsevier Science Ireland Ltd. All rights reserved.
引用
收藏
页码:21 / 28
页数:8
相关论文
共 28 条
[1]   Naringin and naringenin are not the primary CYP3A inhibitors in grapefruit juice [J].
Edwards, DJ ;
Bernier, SM .
LIFE SCIENCES, 1996, 59 (13) :1025-1030
[2]   6′,7′-Dihydroxybergamottin in grapefruit juice and Seville orange juice:: Effects on cyclosporine disposition, enterocyte CYP3A4, and P-glycoprotein [J].
Edwards, DJ ;
Fitzsimmons, ME ;
Schuetz, EG ;
Yasuda, K ;
Ducharme, MP ;
Warbasse, LH ;
Woster, PM ;
Schuetz, JD ;
Watkins, P .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1999, 65 (03) :237-244
[3]  
Edwards DJ, 1996, DRUG METAB DISPOS, V24, P1287
[4]   Specific CYP3A4 inhibitors in grapefruit juice: furocoumarin dimers as components of drug interaction [J].
Fukuda, K ;
Ohta, T ;
Oshima, Y ;
Ohashi, N ;
Yoshikawa, M ;
Yamazoe, Y .
PHARMACOGENETICS, 1997, 7 (05) :391-396
[5]   P-glycoprotein and multidrug resistance [J].
Gottesman, MM ;
Pastan, I ;
Ambudkar, SV .
CURRENT OPINION IN GENETICS & DEVELOPMENT, 1996, 6 (05) :610-617
[6]   UPTAKE AND RETENTION OF ADRIAMYCIN AND DAUNORUBICIN BY SENSITIVE AND ANTHRACYCLINE-RESISTANT SUBLINES OF P388-LEUKEMIA [J].
INABA, M ;
JOHNSON, RK .
BIOCHEMICAL PHARMACOLOGY, 1978, 27 (17) :2123-2130
[7]   Antiproliferative activity of flavonoids on several cancer cell lines [J].
Kawaii, S ;
Tomono, Y ;
Katase, E ;
Ogawa, K ;
Yano, M .
BIOSCIENCE BIOTECHNOLOGY AND BIOCHEMISTRY, 1999, 63 (05) :896-899
[8]   VINCRISTINE-RESISTANT HUMAN CANCER KB-CELL LINE AND INCREASED EXPRESSION OF MULTIDRUG-RESISTANCE GENE [J].
KOHNO, K ;
KIKUCHI, J ;
SATO, S ;
TAKANO, H ;
SABURI, Y ;
ASOH, K ;
KUWANO, M .
JAPANESE JOURNAL OF CANCER RESEARCH, 1988, 79 (11) :1238-1246
[9]  
Kurosawa M, 1996, ANN HEMATOL, V72, P17
[10]   CLEAVAGE OF STRUCTURAL PROTEINS DURING ASSEMBLY OF HEAD OF BACTERIOPHAGE-T4 [J].
LAEMMLI, UK .
NATURE, 1970, 227 (5259) :680-+